Indeed, a single study previously examining the CXCL16/CXCR6 axis in GBM demonstrated that CXL16 expression in myeloid cells (particularly microglia) allows cells to adopt an anti-inflammatory state and that in the context of glioma, it contributes to immunosuppression (50). The gene discussed is CXCL16; the disease is central nervous system cancer.